Latest News
Elon Musk predicts 50% boost to Model 3 battery's power
Tesla boss Elon Musk predicts that his company will be able to mass produce electric batteries for its Model 3 sedans with 50% more power in three to four years' time.
Twitter hides Trump tweet for 'dissuading people from voting'
Twitter hid one of US President Donald Trump’s tweets on Monday warning users that it violated the platform’s regulations against dissuading people from voting.
Liberum stays at 'buy' on Taseko, sees share price doubling in 12 months
Analysts at Liberum reiterated their 'buy' recommendation and 125. 0p target price on shares of Taseko following favourable coverage on the copper miner's shares in the Mail on Sunday, telling clients that they expected the share price to double again over the next 12 months.
Europe close: Stocks end sharply higher, tech and oil issues lead
Stocks held onto their big early gains after news that US health regulators had cleared a potentially key treatment for Covid-19, convalescent plasma, for emergency use and might do something similar with the vaccine being developed by Oxford University.
London close: Stocks firmer on hopes for Covid-19 treatments
London stocks closed higher on Monday, with sentiment boosted by fresh hopes of a coronavirus treatment.
Sector movers: Travel and Leisure boosted by M&A rumours around InterContinental hotels
Mergers and acquisitions news-flow continued to drive sector movements at the sector level, this time in the travel and leisure space.
Tuesday preview: US housing, Polymetal in the spotlight
The focus in financial markets on Tuesday will be on US housing for June with data from the Federal Housing and Finance Agency, alongside figures from S&P Case Shiller both expected to reveal a small further pick up in prices.
Broker tips: Cineworld, Premier Oil
Peel Hunt said on Monday that Cineworld presents "an attractive buying opportunity" for investors with an appetite for material risk.
Director dealings: Hill & Smith director makes share purchase
Hill & Smith revealed on Monday that non-executive director Pete Raby had acquired 1,600 ordinary shares in the FTSE 250-listed construction products manufacturer.
Litigation Capital executes finance agreement with building contractor
Dispute financing company Litigation Capital Management (LCM) has executed a portfolio finance agreement, it announced on Monday, to provide a “significant” finance facility to a subsidiary of a global building and infrastructure contractor, to fund a portfolio of its construction claims.
FTSE 250 movers: Cineworld boosted by broker note; Equiniti falls
London’s FTSE 250 was up 0. 5% at 17,663. 39 in afternoon trade on Monday.
Sector movers: M&A speculation still in the driver's seat, Big Pharma gains
Mergers and acquisitions speculation continued to drive sector moves at the start of the week - yet again.
Europe midday: Stocks higher amid hopes for Covid-19 treatments and vaccines
Stocks are holding onto big early gains as investors cheer news that US health regulators have cleared a potentially key treatment for Covid-19, convalescent plasma, for emergency use and might do something similar with the vaccine being developed by Oxford University.
Jubilee Metals secures 'significant' ore supply agreement
Jubilee Metals Group announced on Monday that it has secured another “significant” ore supply and processing agreement, increasing its long term access to chrome and platinum group metals-rich feed material.
US open: Stocks trade higher on vaccine headlines
Wall Street stocks recorded early gains at the opening bell on Monday as after the Food and Drug Administration issued an emergency use authorisation for convalescent plasma on Covid-19 patients.
Venture Life joins Covid-19 mouthwash trial
Self-care products company Venture Life announced its involvement in a UK-led clinical trial on Covid-19 patients on Monday, in partnership with Cardiff University.
FTSE 100 movers: BT surges; travel stocks retreat
London’s FTSE 100 was up 1. 4% at 6,085. 22 in afternoon trade on Monday.
Tiziana gets US patent for 'TZLS-501' antibody
Biotechnology company Tiziana Life Sciences announced on Monday that the United States Patent and Trademark Office (USPTO) has granted a patent for methods and use of fully human monoclonal antibody ‘TZLS-501’ that recognised both IL-6 receptor (IL-6R) and IL-6 receptor complex with IL-6 (IL-6R/IL-6) for prophylactic and therapeutic intervention for human diseases.
Blackbird starts Live X partnership at Democratic National Convention
Cloud video editing platform provider Blackbird confirmed on Monday today that Live X chose its product for cloud video editing and publishing at the US Democratic National Convention.
Clipper Logistics posts strong FY results, issues upbeat guidance
Clipper Logistics posted a strong set of full-year results on Monday and also issued some upbeat guidance for the current trading year on the back of "exceptionally high demand" for its services.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.